Top Markets
#1 DogBull DogBull +55.14%
#2 Siren Siren +33.22%
#3 OriginTrail OriginTrail +15.34%
#4 Verus Coin Verus Coin +11.33%
#5 Yield Basis Yield Basis +9.55%
#6 龙虾 (Lobster) 龙虾 (Lobster) +7.54%
#7 Stargate Finance Stargate Finance +7.00%
#8 LayerZero LayerZero +6.90%
#9 MEET48 MEET48 +6.66%
#10 Falcon Finance Falcon Finance +6.50%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Brii Biosciences Limited Brii Biosciences Limited

Brii Biosciences Limited

2137
Classifica tra le azioni #22138
Founded in Beijing, China, in 2017, Brii Biosciences Limited is a... Founded in Beijing, China, in 2017, Brii Biosciences Limited is a biopharmaceutical firm dedicated to discovering and developing innovative therapies for infectious diseases and central nervous system disorders. Its diverse pipeline features: early-stage (Phase 1) compounds BRII-778 and BRII-732 for treating HIV; a multifaceted approach to Hepatitis B (HBV) including a Phase 2 combination study of BRII-179 and BRII-835, with BRII-179 (a recombinant protein-based immunotherapeutic) also in Phase 1b/2a, and BRII-835 having successfully completed Phase 2 for chronic HBV patients. The company also offers the Amubarvimab/romlusevimab combination as a treatment for COVID-19. Beyond these, Brii Biosciences is advancing BRII-296 for PPD and BRII-297 for various depressive conditions, alongside several agents targeting highly resistant infections: BRII-636, BRII-672, and BRII-693 are designed to combat multi-drug and extensively drug-resistant (MDR/XDR) gram-negative bacteria, while BRII-658 is under development for MDR/XDR tuberculosis and non-tuberculosis mycobacterial infections.
Prezzo delle azioni
$0.12984512
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$93.64M
Variazione (1 giorno)
3.57%
Variazione (1 anno)
-49.27%
Paese
CN
Scambia Brii Biosciences Limited (2137)

Categoria

Healthcare
Storico dividendi per Brii Biosciences Limited (2137)
Brii Biosciences Limited (simbolo azionario: 2137) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Brii Biosciences Limited (2137) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH